Larvol Delta - Viracta-Therapeutics-Announces-Preliminary-DoseRanging-Data-from-the-Phase-1b2-Trial-of-Nanaval-in-Advanced-EpsteinBarr-VirusPositive-EBV-Solid-Tumors-at-the-ESMO-ImmunoOncology-Congress

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2022/11/30/2565495/0/en/Viracta-Therapeutics-Announces-Preliminary-Dose-Ranging-Data-from-the-Phase-1b-2-Trial-of-Nana-val-in-Advanced-Epstein-Barr-Virus-Positive-EBV-Solid-Tumors-at-the-ESMO-Immuno-Oncol.html

Nov 30, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next